(Q35625240)

9 August 2017

1 reference

title

Central nervous system lupus: a clinical approach to therapy (English)

1 reference

9 August 2017

G Sanna

1

1 reference

9 August 2017

M L Bertolaccini

series ordinal

2

1 reference

9 August 2017

A Mathieu

series ordinal

3

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

12

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

935-942

1 reference

Controversies in lupus: nervous system involvement

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Lupus and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

The central nervous system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Patients with refractory seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Central nervous system involvement in the antiphospholipid (Hughes) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Migrainous phenomena in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Treatment of lupus with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Cognitive effects of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Glucocorticoid medication, memory and steroid psychosis in medical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Acute transverse myelopathy complicating systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Cyclophosphamide for the treatment of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Intravenous immunoglobulin treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Psychiatric disorder and cognitive impairment in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU505OA

10.1191/0961203303LU505OA

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference